Vital

When the medication isn't working

Wegovy Not Working? What to Check and When to Ask

If Wegovy is not working the way you hoped, check the dose step, the 16-week titration, missed doses, and how you measure progress. Then bring a clear record to your prescriber.

Last reviewed

The Vital angle

Vital logs each Wegovy dose with the date, amount, and site, so the date you reached each step of the 16-week ramp and any missed weeks are on record. Your weight trend from Apple Health sits next to that dose history, which makes the 12-weeks-on-full-dose check easy to see and easy to share with your prescriber.

Many people search "Wegovy not working" in their second or third month, when hunger comes back between doses or the scale moves less than expected. Wegovy (semaglutide) is one of the most studied weight management medications, but its label builds in a long ramp before you reach a maintenance dose. The time on that ramp, plus how you measure results, explains a large share of early worry.

This guide walks through what the label says to expect, what can weaken the effect, and how to have a useful talk with your prescriber. It gives no dose advice. Your prescriber decides any change to dose or treatment.

What a typical Wegovy response looks like

The main weight trial in the Wegovy label followed adults without diabetes for 68 weeks. People on Wegovy 2.4 mg lost an average of 14.9 percent of body weight, compared with 2.4 percent on placebo. About 83 percent lost at least 5 percent, and about two thirds lost at least 10 percent.

Two details in those numbers matter for you:

  • About 1 in 6 people on Wegovy did not reach 5 percent loss. A smaller response is a known outcome, not a sign that you did something wrong.
  • In the trial of adults with type 2 diabetes, average loss was 9.6 percent. If you have diabetes, a smaller number than the headline figure is expected.

The curve is also not a straight line. Loss is usually faster in the first months and slows as you approach your new weight. If your loss slowed after a good start, read weight loss plateaus before you assume Wegovy stopped working.

The 16-week ramp

The label sets this injection schedule to lower stomach side effects:

Weeks Weekly dose
1 to 4 0.25 mg
5 to 8 0.5 mg
9 to 12 1 mg
13 to 16 1.7 mg
17 onward Maintenance

For weight reduction in adults, the maintenance dose is 1.7 mg or 2.4 mg (the label recommends 2.4 mg). For people who tolerate 2.4 mg for at least 4 weeks and need more weight reduction, the label now allows an increase to a maximum of 7.2 mg. If a step causes side effects you cannot tolerate, the label lets the prescriber delay the next step by 4 weeks.

This means a person who started in January may not reach the maintenance dose until May, or later if a step was delayed. Judging Wegovy on its first 8 weeks is judging it on the two lowest doses.

How long to wait before calling it a non-response

The NIDDK gives a clear rule for weight management medications in general: if you are not losing weight after 12 weeks on the full dose, ask your health care professional whether you should stop taking it. The key words are "full dose." With Wegovy, that clock usually starts after the ramp, not on day one.

A simple way to track it:

  1. Write down the date you reached your maintenance dose.
  2. Use your weight on that date as a second baseline, next to your starting weight.
  3. Review your 4-week average trend at weeks 4, 8, and 12 after that date.
  4. Bring both numbers, total loss and loss since maintenance, to your prescriber.

Things that can blunt the effect

Before you and your prescriber talk about a change, rule out these common causes.

Missed doses. The label has a 2-day rule for a missed injection: what to do depends on how close your next scheduled dose is. If you miss 2 or more doses in a row, the label tells the prescriber to restart titration at a lower dose. Do not restart on your own, and ask your pharmacist or prescriber if you are not sure which rule applies. See missed GLP-1 dose.

Storage and the pen. Keep pens refrigerated at 36°F to 46°F and never freeze them. Single-dose pens can stay at 46°F to 86°F for up to 28 days. A pen left in a hot car or frozen may not work as intended. Ask your pharmacist before you use one. If the pen did not seem to inject, see Wegovy pen not injecting.

Food and drink patterns. Less hunger does not stop liquid calories, alcohol, or grazing. Many people find that two weeks of honest food logging shows where the gap is.

Muscle and protein. Fast loss with low protein can cost lean mass. Aim for regular protein at each meal and some resistance training. See protein on GLP-1.

Sleep, stress, and other medicines. Short sleep and long stress make appetite harder to manage. Some other medicines can also affect appetite or weight. Ask your prescriber to review your full list.

Compounded products. The FDA has not approved compounded semaglutide. It warns that some products use salt forms that are different active ingredients, and it has reports of dosing errors when people measure compounded injections themselves. If you switched from brand Wegovy to a compounded product and results changed, tell your prescriber. See compounded vs brand semaglutide.

If hunger returns late in the week

Some people feel food noise come back a day or two before their next shot. The label does not say to change the dose day or dose size for it. Useful steps that do not change your medication:

  • Plan protein-rich meals and filling snacks for the last two days of the week.
  • Keep a short note of the day hunger returns, so you can see whether the pattern is steady.
  • Ask your prescriber about the pattern if it does not fade after you reach maintenance.

Food noise back on GLP-1 has more detail.

Wegovy tablets have different rules

The Wegovy label now includes a once-daily tablet. If you take the tablet, absorption depends on how you take it:

  1. Take one tablet in the morning on an empty stomach.
  2. Use plain water only, up to 4 ounces.
  3. Swallow it whole. Do not split, crush, or chew it.
  4. Wait at least 30 minutes before you eat, drink, or take other oral medicines.

Coffee, juice, or breakfast too soon after the tablet can lower how much medicine your body takes in. The label also has a missed-tablet rule, and it says never to take more than one tablet a day. Ask your pharmacist if you miss a morning and are not sure what to do. For more on oral semaglutide, see Rybelsus not working.

What to bring to your prescriber

A useful visit starts with facts, not a feeling that "it is not working." Bring:

  • Your start date and the date you reached each dose step.
  • Any missed or late doses.
  • A weight trend, ideally weekly averages, from start and from the maintenance date.
  • Side effects, how severe they were, and whether they held back a dose step.
  • Your other medicines and any big changes in sleep, stress, or health.

With that record, your prescriber can judge whether you need more time, a different maintenance dose, help with side effects, or a different medication. If tirzepatide is an option, switching semaglutide to tirzepatide explains what to expect.

Warning signs that need care now

Get medical care right away for:

  • Severe stomach pain that does not go away, with or without vomiting.
  • Upper right belly pain, fever, yellow skin or eyes, or clay-colored stool.
  • Swelling of the face, lips, tongue, or throat, trouble breathing, or a severe rash.
  • Vomiting or diarrhea that stops you from keeping fluids down, or much less urine than usual.
  • Changes in vision, if you have diabetes with eye disease.
  • A lump in the neck, trouble swallowing, or lasting hoarseness.

These are safety problems, not signs that the dose is too low. Do not wait for a routine visit.


Wegovy® is a trademark of Novo Nordisk A/S. Vital is independent and not affiliated with these companies.

Free toolGLP-1 medication level chart

Things to watch

Practical flags drawn from prescribing information and clinical guidance. Vital surfaces these in the dose log to help you spot them early.

  • Judging Wegovy during the titration ramp

    The label takes 16 weeks to reach a maintenance dose. The first 8 weeks use the two lowest doses, so early results do not show the full effect.

  • Missing 2 or more doses in a row

    The label tells the prescriber to restart titration at a lower dose after 2 or more consecutive missed doses. Restarting at your old dose on your own can raise the risk of strong stomach side effects.

  • Comparing yourself to the 15 percent average

    About 1 in 6 people in the main trial lost less than 5 percent, and adults with type 2 diabetes lost 9.6 percent on average. A smaller result can still be a real response.

  • Pens exposed to heat or freezing

    Wegovy must not be frozen, and single-dose pens can stay at 46°F to 86°F for only up to 28 days. Ask a pharmacist before you use a pen that was outside these limits.

  • Tablets taken with coffee or food

    Wegovy tablets need plain water only, up to 4 ounces, and a 30-minute wait before food, drinks, or other oral medicines. Taking them differently can lower absorption.

  • Severe stomach pain or yellow skin

    The label lists pancreatitis and gallbladder disease as possible problems. Severe lasting belly pain, fever, or yellow skin or eyes need medical care right away.

Frequently asked questions

  • The injection ramp takes 16 weeks before maintenance. Many people notice less hunger earlier, but the NIDDK suggests judging a weight medication after 12 weeks on the full dose. For Wegovy, that usually means around week 28 or later.

  • Common causes are time on low starting doses, missed doses, pens stored outside the label limits, and eating patterns that leave room for liquid calories or snacks. Some people also respond less than average. Bring your dose dates and weight trend to your prescriber.

  • In the main 68-week trial of adults without diabetes, about 83 percent lost at least 5 percent of body weight, so about 1 in 6 did not. In adults with type 2 diabetes, average loss was smaller.

  • Only your prescriber can decide that. The label allows maintenance at 1.7 mg or 2.4 mg, and for people who tolerate 2.4 mg for at least 4 weeks and need more weight reduction, an increase to a maximum of 7.2 mg.

  • Some people feel more hunger near the end of the week. Plan filling, protein-rich meals for those days, keep a note of the pattern, and ask your prescriber if it does not fade after you reach maintenance. Do not move your dose day on your own.

  • The tablet only works as intended if you take it the label way: empty stomach, plain water up to 4 ounces, swallowed whole, and a 30-minute wait before food, drinks, or other medicines. Ask your prescriber which form fits you.

Sources

  1. WEGOVY (semaglutide) Prescribing Information · Novo Nordisk
  2. Wegovy Pen Guide and Dosing Information · Novo Nordisk
  3. Prescription Medications to Treat Overweight & Obesity · NIDDK, National Institutes of Health
  4. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) · New England Journal of Medicine
  5. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss · U.S. Food and Drug Administration

This page summarizes publicly available information from the sources listed above and is for educational use only. It is not medical advice. Consult a qualified healthcare professional for personal dosing guidance.

Track every shot, every change

Vital logs every GLP-1 injection and peptide dose, then surfaces patterns your scale can't show. Free on iOS and Android.